课题基金 / 基金详情

Targeting Rab27A with covalent inhibitors and Exocytosis TArgeting Chimeras (ExoTACs) for lung cancer treatment

Targeting Rab27A with covalent inhibitors and Exocytosis TArgeting Chimeras (ExoTACs) for lung cancer treatment
使用共价抑制剂和胞吐作用靶向嵌合体 (ExoTAC) 靶向 Rab27A 用于肺癌治疗
批准号:
EP/X02749X/1
负责人:
Edward Tate
金额:
$26.0万
依托单位:
依托单位国家:
英国
项目类别:
Fellowship
财政年份:
2022
资助国家:
英国
项目状态:
未结题
起止时间:
2022 至 --

项目摘要

项目成果

Edward Tate的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Small monomeric guanosine triphosphatases (GTPases) are a group of hydrolase enzymes that bind to and hydrolyse a guanosine triphosphate (GTP) to form guanosine diphosphate (GDP). GTP-bound small GTPases can recruit specific effectors through protein-protein interactions (PPIs) to trigger signalling cascades in cells. Rab27A is a small GTPase protein playing a key role in secretion of exosomes, membrane-bound vesicles responsible for intercellular communication and cell migration. GTP-bound Rab27A mediates the release of exosomes by binding to its effectors such as Slp2a. Several studies have shown that loss of Rab27A expression impairs cancer cell invasion and metastasis due to reduction of pro-invasive exosomes. Therefore, targeting Rab27A is a promising strategy to overcome metastasis and drug resistance in lung cancer. However, Rab27A is a very challenging target due to its conformational flexibility and the lack of canonical binding pockets beyond the widely conserved GTP binding site. The host lab (Tate) used a covalent ligand approach to target two non-conserved cysteines in proximity to the effector binding site on Rab27 isoforms and identified the first bona fide Rab27A ligand series, with optimized hits exhibiting high selectivity for Cys123, strong interference with the Rab27A-Slp2 effector PPI, and moderate proteome-level selectivity (unpublished results). In this project, I will (1) optimize these starting points to design the first proteome-wide selective Rab27A inhibitor to interfere with its binding to effectors, subsequently (2) characterizing its impact on exosome secretion, invasion and growth of lung cancer cells. In the second part of the project, I will (3) develop a new class of bifunctional molecules termed Exocytosis TArgeting Chimeras (ExoTACs), linking a selective Rab27A ligand with a ligand to a target protein, enabling for the first time compound-induced exocytosis of a target protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A proteomics platform to enable next generation multidisciplinary bioscience
  • 批准号:
    BB/W019574/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $55.29万
  • 财政年份:
    2022
  • 负责人:
    Edward Tate
  • 依托单位:
Hedgehog acyltransferase : structure and function in health and disease
  • 批准号:
    BB/T01508X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $105.41万
  • 财政年份:
    2020
  • 负责人:
    Edward Tate
  • 依托单位:
A surface plasmon resonance facility for label-free analysis of biomolecular interactions
  • 批准号:
    BB/S019529/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $23.28万
  • 财政年份:
    2019
  • 负责人:
    Edward Tate
  • 依托单位:
N-Myristoyl Transferase as a drug target for anti-malarial therapy
  • 批准号:
    G0900278/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $179.17万
  • 财政年份:
    2010
  • 负责人:
    Edward Tate
  • 依托单位:
国内基金
海外基金
突触结合样蛋白5通过RAB27a调控甲状腺 乳头状癌转移的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2025
  • 负责人:
    余诗桐
  • 依托单位:
FOS转录调控Rab27a促进肌腱干细胞分泌外泌体修复肌腱损伤机制的研究
  • 批准号:
    JCZRLH202500509
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
Rab27A通过调节miR-124-3p/STAT3轴在浆液性卵巢癌发生中的作用机制研究
  • 批准号:
    2023JJ40822
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2023
  • 负责人:
    贺莎莎
  • 依托单位:
HIF-1a/Rab27a信号轴调控低氧来源NSC-EXs生成在血管性痴呆治疗中的作用及机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    10.0万元
  • 批准年份:
    2022
  • 负责人:
    潘群文
  • 依托单位: